ArticleCancer letters2021

Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.

Christina A Wicker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.